Maaike M. E. Jacobs
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Maaike M. E. Jacobs has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Raphaël Duivenvoorden
Department of Nephrology, Radboud University Medical Center, Nijmegen, the Netherlands (L.C.d.J., N.R., R.D.).
3 shared publications - Leo A. B. Joosten
Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
2 shared publications - Luuk Hilbrands
Department of Nephrology, Radboud University Medical Center, Nijmegen, the Netherlands
2 shared publications Marijke Baltissen
Department of Molecular Biology, Faculty of Science, Oncode Institute, Radboud University Nijmegen, Nijmegen, The Netherlands
2 shared publications- Mihai Gheorghe Netea
Department of Internal Medicine, Radboud University Medical Center, Nijmegen, Netherlands
2 shared publications - Nils Rother
Department of Nephrology, Radboud University Medical Center, Nijmegen, the Netherlands
2 shared publications
Latest Publications
- Open Access
- 7 September 2026
- Published by Elsevier in American Journal of Transplantation
The interplay between innate immune memory and adaptive immunity: Emerging mechanisms in alloimmunity
- 7 September 2026
- Published by Elsevier in American Journal of Transplantation
Open AccessThe interplay between innate immune memory and adaptive immunity: Emerging mechanisms in alloimmunity
- Open Access
- 23 August 2024
- Published by Elsevier in Cell Reports
- Vol. 43 (9) , 114664
Trained immunity is regulated by T cell-induced CD40-TRAF6 signaling
- 23 August 2024
- Published by Elsevier in Cell Reports
- Vol. 43 (9) , 114664
Open AccessTrained immunity is regulated by T cell-induced CD40-TRAF6 signaling
- Open Access
- 13 August 2024
- Published by Elsevier in American Journal of Transplantation
- Vol. 24 (11) , 2022-2033
Trained immunity suppression determines kidney allograft survival
- 13 August 2024
- Published by Elsevier in American Journal of Transplantation
- Vol. 24 (11) , 2022-2033
Open AccessTrained immunity suppression determines kidney allograft survival
- Open Access
- 8 May 2023
- Published by Springer Nature in Archives of Toxicology
- Vol. 97 (7) , 1927-1941
Metabolic impact of genetic and chemical ADP/ATP carrier inhibition in renal proximal tubule epithelial cells
Mitochondrial dysfunction is pivotal in drug-induced acute kidney injury (AKI), but the underlying mechanisms remain largely unknown. Transport proteins embedded in the mitochondrial inner membrane form a significant class of potential drug off-targets. So far, most transporter-drug interactions have been reported for the mitochondrial ADP/ATP carrier (AAC). Since it remains unknown to what extent AAC contributes to drug-induced mitochondrial dysfunction in AKI, we here aimed to better understand the functional role of AAC in the energy metabolism of human renal proximal tubular cells. To this end, CRISPR/Cas9 technology was applied to generate AAC3−/− human conditionally immortalized renal proximal tubule epithelial cells. This AAC3−/− cell model was characterized with respect to mitochondrial function and morphology. To explore whether this model could provide first insights into (mitochondrial) adverse drug effects with suspicion towards AAC-mediated mechanisms, wild-type and knockout cells were exposed to established AAC inhibitors, after which cellular metabolic activity and mitochondrial respiratory capacity were measured. Two AAC3−/− clones showed a significant reduction in ADP import and ATP export rates and mitochondrial mass, without influencing overall morphology. AAC3−/− clones exhibited reduced ATP production, oxygen consumption rates and metabolic spare capacity was particularly affected, mainly in conditions with galactose as carbon source. Chemical AAC inhibition was stronger compared to genetic inhibition in AAC3−/−, suggesting functional compensation by remaining AAC isoforms in our knockout model. In conclusion, our results indicate that ciPTEC-OAT1 cells have a predominantly oxidative phenotype that was not additionally activated by switching energy source. Genetic inhibition of AAC3 particularly impacted mitochondrial spare capacity, without affecting mitochondrial morphology, suggesting an important role for AAC in maintaining the metabolic spare respiration.
- 8 May 2023
- Published by Springer Nature in Archives of Toxicology
- Vol. 97 (7) , 1927-1941
Open AccessMetabolic impact of genetic and chemical ADP/ATP carrier inhibition in renal proximal tubule epithelial cells
Mitochondrial dysfunction is pivotal in drug-induced acute kidney injury (AKI), but the underlying mechanisms remain largely unknown. Transport proteins embedded in the mitochondrial inner membrane form a significant class of potential drug off-targets. So far, most transporter-drug interactions have been reported for the mitochondrial ADP/ATP carrier (AAC). Since it remains unknown to what extent AAC contributes to drug-induced mitochondrial dysfunction in AKI, we here aimed to better understand the functional role of AAC in the energy metabolism of human renal proximal tubular cells. To this end, CRISPR/Cas9 technology was applied to generate AAC3−/− human conditionally immortalized renal proximal tubule epithelial cells. This AAC3−/− cell model was characterized with respect to mitochondrial function and morphology. To explore whether this model could provide first insights into (mitochondrial) adverse drug effects with suspicion towards AAC-mediated mechanisms, wild-type and knockout cells were exposed to established AAC inhibitors, after which cellular metabolic activity and mitochondrial respiratory capacity were measured. Two AAC3−/− clones showed a significant reduction in ADP import and ATP export rates and mitochondrial mass, without influencing overall morphology. AAC3−/− clones exhibited reduced ATP production, oxygen consumption rates and metabolic spare capacity was particularly affected, mainly in conditions with galactose as carbon source. Chemical AAC inhibition was stronger compared to genetic inhibition in AAC3−/−, suggesting functional compensation by remaining AAC isoforms in our knockout model. In conclusion, our results indicate that ciPTEC-OAT1 cells have a predominantly oxidative phenotype that was not additionally activated by switching energy source. Genetic inhibition of AAC3 particularly impacted mitochondrial spare capacity, without affecting mitochondrial morphology, suggesting an important role for AAC in maintaining the metabolic spare respiration.